We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Boehringer Ingelheim Limited

The Crescent Building, , Northwood, Santry, Dublin 9,
Telephone: +353 1 295 9620
Fax: : +353 1 816 3642
Medical Information e-mail: Medinfo@dbl.boehringer-ingelheim.com
Patient Information Leaflet last updated on medicines.ie: 04/12/2015
PIL Atrovent UDVs 2ml

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 04/12/2015 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to dosage and administration
Updated on 28/07/2014 and displayed until 04/12/2015
Reasons for adding or updating:
  • Change to date of revision
  • Change to name of manufacturer
  • Addition of information on reporting a side effect.
Updated on 06/10/2010 and displayed until 28/07/2014
Reasons for adding or updating:
  • Change to side-effects
  • Change to information about driving or using machinery
  • Change to date of revision
Updated on 27/08/2010 and displayed until 06/10/2010
Reasons for adding or updating:
  • Change of manufacturer
Updated on 26/09/2008 and displayed until 27/08/2010
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 22/03/2007 and displayed until 26/09/2008
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 23/05/2006 and displayed until 22/03/2007
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 14/09/2004 and displayed until 23/05/2006
Reasons for adding or updating:
  • New PIL for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   ipratropium bromide monohydrate